Understand · Treat · Recover
Early Gastric Cancer and Endoscopic Treatment
Some superficial gastric cancers can be removed through an endoscope, preserving the stomach when lymph-node risk is sufficiently low.
For patients, families and caregivers worldwide. Approvals, access and care pathways vary by country. Evidence checked 21 October 2026.
This information is provided for general educational purposes and does not replace individualized medical advice. Diagnosis and treatment decisions should be made with a qualified healthcare team.
Chapter 8 of 20
What “early” means
Early gastric cancer is confined to the mucosa or submucosa, regardless of nodal status. This anatomical definition does not mean every early cancer is suitable for endoscopic treatment. The key question is whether the lesion can be completely removed and whether the risk of cancer in lymph nodes is low enough to avoid an operation that removes nodes.
EMR and ESD
Endoscopic mucosal resection (EMR) lifts and snares a superficial lesion. Endoscopic submucosal dissection (ESD) carefully cuts beneath it, often allowing a larger lesion to be removed in one piece. ESD gives the pathologist a better specimen for judging margins and invasion, but is technically demanding and carries bleeding and perforation risks. It should be performed by an experienced team.
How selection works
Assessment considers depth, size, ulceration, differentiation and signs of lymph-node involvement. Selected differentiated intramucosal cancers without ulceration are particularly suitable; some other lesions can qualify under expert guideline criteria. A small lesion is not automatically safe to remove endoscopically, and undifferentiated or signet-ring features require careful specialist assessment. Criteria for Barrett-associated junctional lesions differ from gastric criteria.
The final specimen decides whether treatment was enough
A curative endoscopic resection requires favourable pathology, including adequate margins and acceptable invasion and lymphovascular-risk features. Deeper invasion, cancer in lymphatic or blood vessels, or a positive deep margin may lead to gastrectomy with nodal surgery. A limited horizontal margin issue without other high-risk findings may instead allow further endoscopic treatment or surveillance. The team should explain the reason for any recommended additional surgery.
After the procedure
Follow the unit’s eating, acid-suppression and medication instructions. Vomiting blood, black stools with weakness, severe pain, fever or collapse need urgent assessment. Scheduled endoscopy checks healing and detects new lesions in the retained stomach. H. pylori should be addressed when present. Keeping the stomach does not remove the need for follow-up, because the surrounding lining may remain at risk.
Key takeaways
Endoscopic cure depends on favourable pathology and low lymph-node risk, not just lesion size.
Frequently asked questions
Is ESD the same as keyhole surgery?
No. ESD works through an endoscope inside the digestive tract, without removing the stomach through abdominal incisions.
Can ESD remove lymph nodes?
No. Low nodal risk is essential to selection.
Can surgery still be needed after ESD?
Yes, if the final pathology shows a meaningful risk of residual or nodal disease.
Does one-piece removal always mean cure?
No. Margins, depth and other pathological features must also be favourable.
Will I still need endoscopy later?
Yes. Surveillance of the retained stomach remains important.
Is endoscopic treatment appropriate for stage IV cancer?
It is not a curative treatment for metastatic disease, although endoscopic procedures can sometimes relieve symptoms.